Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics (Q36192663)

12 August 2017

1 reference

title

Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics (English)

1 reference

attention deficit hyperactivity disorder

12 August 2017

1 reference

1 reference

1 reference

5

1 reference

12 August 2017

4

Tatiana Roman

1 reference

12 August 2017

6

Luis Augusto Rohde

1 reference

PubMed ID

16013954

12 August 2017

Guilherme V Polanczyk

series ordinal

1

object named as

Guilherme Polanczyk

1 reference

12 August 2017

2

Cristian Zeni

1 reference

PubMed ID

16013954

12 August 2017

Júlia Pasqualini Genro

series ordinal

3

object named as

Julia P Genro

1 reference

12 August 2017

1 April 2005

1 reference

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

3

1 reference

12 August 2017

225-234

1 reference

Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Genetics of childhood disorders: XX. ADHD, Part 4: is ADHD genetically heterogeneous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Dopamine transporter gene associated with diminished subjective response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Association of norepinephrine transporter gene with methylphenidate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

21 January 2018

Dopamine genes and ADHD.

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Genotype influences in vivo dopamine transporter availability in human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Functional effects of the DAT1 polymorphism on EEG measures in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

The policy and ethical implications of genetic research on attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

Attention-Deficit/Hyperactivity Disorder in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.225

21 January 2018

Identifiers

DOI

10.1517/14622416.6.3.225

1 reference

12 August 2017

1 reference

PubMed ID

16013954